Phase I Market Outlook: 2018-2022
$4,460.00 – $8,920.00
Related products
-
Improving Patient Recruitment and Feasibility: Recommendations from Site Coordinators
$4,900.00 – $7,350.00 -
Central Lab Market Dynamics and Outsourcing Performance
$3,960.00 – $7,920.00 -
Optimizing Feasibility in Clinical Trials
$2,460.00 – $4,920.00 -
CRO Quality Benchmarking – Phase II/III Service Providers (5th edition)
$6,800.00 – $13,600.00